A stem-cell first for macular degeneration
Monday 15 February 2016In a pioneering clinical trial, a patient with macular degeneration has been treated using lab-grown stem cells at University College London. The trial will test if it is safe and effective to transplant a type of eye cell grown from stem cells in the lab to restore sight in people with severe visual loss from wet AMD.
Surgery involves inserting a specially developed patch at the back of the eye behind the retina in order to replace diseased cells. A female patient underwent surgery in August 2015, and a further nine patients are due to be recruited to the trail over the next year and a half subject to assessment of the success of the initial operation.
Co-leader of the research Professor Pete Coffey says: “Although we recognise this clinical trial focuses on a small group of AMD patients who have experienced sudden severe visual loss, we hope that many patients may benefit in the future.”
Sources:
Comments
Post a comment…
A Serious Blog
News and views from around the world on lighting, eyecare and eye conditions.
Twitter: @seriousreaders
Facebook:facebook.com/seriousreaders
Recent posts
- Why is it so challenging to treat dry-eye?
- Living with Glaucoma: National Eye Health Week
- Autumn Equinox: A Balance of Light and Darkness
- The impact of light on productivity and performance
- What are seven secret ingredients for healthier eyes?
Don't miss out on exclusive content and all the latest in light and sight. Subscribe to our email list now!